术前肠道菌群对乳腺癌幸存者慢性术后疼痛的预测与预防潜力
该研究采用嵌套病例对照设计,比较66例伴与不伴慢性术后疼痛(CPP)的乳腺癌幸存者术前肠道菌群,发现两组菌群组成显著不同,加入差异菌群可提升临床预测模型的判别能力;动物实验将患者粪菌移植给小鼠并采用 spared nerve injury 模型,发现「CPP菌群」受体小鼠机械性痛觉过敏加重、脊髓 Ppar-γ 与 Arg-1 表达下降。结论提示术前肠道菌群可能预测并预防 CPP,经脊髓 PPAR-γ-小胶质细胞通路发挥因果作用。
要点
- 乳腺癌幸存者术前肠道菌群组成与 CPP 发生相关,或可作为预测指标。
- 将差异菌群纳入临床预测模型可提升判别能力(属水平 AUC 提高 0.099)。
- 动物实验提示肠道菌群经脊髓 PPAR-γ-小胶质细胞通路因果性影响 CPP。
核心结论
- 术前肠道菌群有潜力预测和预防乳腺癌幸存者慢性术后疼痛(CPP)的发生,并可能通过脊髓 PPAR-γ-小胶质细胞通路发挥因果作用。
研究设计与样本
- 临床部分为嵌套病例对照研究,使用 16s rRNA 测序比较伴与不伴 CPP 的乳腺癌幸存者术前肠道菌群,主要结局为术后 3 个月手术区或周围有临床意义的疼痛。
- 动物部分将伴与不伴 CPP 患者的术前粪菌移植给小鼠,采用 spared nerve injury(SNI)模型模拟神经病理性疼痛,评估机械性痛觉过敏及脊髓小胶质细胞与 PPAR-γ 标志物表达。
主要发现
- 共分析 66 例 CPP 患者与 66 例匹配对照,两组术前肠道菌群在门、科、属水平组成显著不同。
- 纳入差异菌群后,临床预测模型的判别能力(以 ROC 曲线下面积衡量)在科水平提高 0.039、属水平提高 0.099。
- 粪菌移植后,「CPP 菌群」受体小鼠机械性痛觉过敏显著加重,脊髓 Ppar-γ 与 arginase-1(Arg-1)表达显著下降。
临床怎么用
- 对乳腺癌手术患者,术前肠道菌群信息或可辅助识别 CPP 高风险个体,并作为预防策略的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evidence suggests a potential relationship between gut microbiota and chronic postoperative pain (CPP). This study aimed to explore the predictive and preventive potential of preoperative gut microbiota in CPP in breast cancer survivors. METHODS: In the clinical experiments, we designed a nested case-control study to compared preoperative gut microbiota of breast cancer survivors with and without CPP using 16s rRNA sequencing. The primary outcome was clinically meaningful pain in or around the operative area 3 months after surgery. Logistic prediction models based on previously identified risk factors for CPP in breast cancer survivors were tested with and without differential bacteria to evaluate the model's potential for improvement with the addition of gut microbiota information. In the animal experiments, preoperative fecal microbiota was transplanted from patients with and without CPP to mice, and a spared nerve injury (SNI) model was used to mimic neuropathic pain in CPP. Mechanical hyperalgesia and the expression of markers of spinal microglia and peroxisome proliferator-activated receptor-γ (PPAR-γ) were assessed. RESULTS: Sixty-six CPP patients and 66 matched controls were analyzed. Preoperative gut microbiota composition was significantly different in the 2 groups at phylus, family, and genera levels. The discrimination of the clinical prediction model (determined by area under the receiver operating characteristic curve) improved by 0.039 and 0.099 after the involvement of differential gut microbiota at the family and genus levels, respectively. After fecal microbiota transplantation (FMT), "CPP microbiota" recipient mice exhibited significantly increased mechanical hyperalgesia and decreased expression of Ppar-γ and arginase-1 (Arg-1) in the spinal cord. CONCLUSIONS: Preoperative gut microbiota has the potential to predict and prevent the development of CPP and plays a causal role in its development via the PPAR-γ-microglia pathway in the spinal cord. Thus, it could be targeted to develop a prevention strategy for CPP in breast cancer survivors.
引用
- Yao ZW, Yang X, Zhao BC, et al. Predictive and Preventive Potential of Preoperative Gut Microbiota in Chronic Postoperative Pain in Breast Cancer Survivors. Anesth Analg. 2022. PMID: 34403381. doi:10.1213/ANE.0000000000005713
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。